Serious adverse events with tedizolid and linezolid: pharmacovigilance insights through the FDA adverse event reporting system.
Expert Opin Drug Saf
; 20(11): 1421-1431, 2021 Nov.
Article
in En
| MEDLINE
| ID: mdl-34280062
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tetrazoles
/
Adverse Drug Reaction Reporting Systems
/
Oxazolidinones
/
Linezolid
/
Anti-Bacterial Agents
Type of study:
Etiology_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
America do norte
Language:
En
Journal:
Expert Opin Drug Saf
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: